RSV is the most common viral cause of respiratory infections in young children Get its treatment RSV Testing in Calabasas with Malibu Canyon Health anytime.
RSV symptoms are very similar to other common childhood illnesses (such as common cold). Some of the symptoms are:
Fevers
Cough
Wheezing
Runny nose
Decreased appetite
Low energy/fussiness
These symptoms are similar to most other common colds. As such, in most cases the infection is mild and will resolve in 1-2 weeks. However, in some cases, RSV can lead to more serious illness such pneumonia or bronchiolitis. Bronchiolitis is from inflammation of the smaller airways in the lungs leading to severe coughing, wheezing and difficulty breathing. These illnesses can be especially dangerous in premature babies or young children with heart or lung disease or in people with weakened immune systems.
For more severe cases, your Pediatrician or healthcare provider will check for secondary bacterial infectious causes such as an ear infection or pneumonia that may need antibiotic treatment. A small percentage of children, about 0.5 - 2%, will need to be hospitalized to receive treatment. Most of the hospitalized children are under the age of 6 months. Hospital treatment may include use of an oxygen mask, ventilator or IV fluids (intravenous) if your child is having difficulty with eating and drinking. For high risk young children, such as ones who have heart or lung disease, there is medication that is a monthly injection that helps prevent more serious illness from RSV. If you think your child may benefit from this, talk to your child’s pediatrician.
According to the new market research report RSV Diagnostics Market is expected to reach USD 929.2 Million by 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95683942 Factors driving the growth of this market include rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays.North America is estimated to command the largest share of the market during the forecast period.Based on region, the Respiratory Syncytial Virus Diagnostics Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).
North America is estimated to dominate the RSV diagnostics market in 2017.
This is mainly due to factors such as the increasing patient base of RSV diseases, technological advancements in PoC molecular diagnostic devices, and growing healthcare expenditures.Based on method, the market is segmented into molecular diagnostics, rapid antigen detection tests, and other methods.
The molecular diagnostics segment is estimated to register the highest growth during the forecast period.Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=95683942Based on end user, the market is segmented into hospitals & clinics and home care.
The hospitals and clinics segment is estimated to grow at the highest rate during the forecast period.
Global RSV Diagnostics Market Research Report: By Product (Kits and Assays, Others), by Method (Rapid Antigen Detection Tests, Molecular Diagnostic Tests, Others), By End-User (Hospital and Clinics, Clinical Laboratory, Others) – Global Forecast Till 2023Market HighlightsRespiratory Syncytial Virus (RSV) is a virus that can cause serious respiratory infections such as pneumonia and bronchitis.
The increasing incidence rate of respiratory infections, growing demand for in-vitro diagnostics, and growing neonatal population are major factors propelling the growth of the market.
For instance, according to the Centres for Disease Control and Prevention, in the United States, RSV on an average lead to 57,527 hospitalizations among children below five years of age.
On the other hand, some factor such as lack of availability of specific treatment options for RSV infections and the high number of other pathogens that cause similar symptoms of respiratory illness may hamper the growth of the market during the assessment period.Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/6217Regional AnalysisThe Americas is likely to dominate the global RSV diagnostics market during the forecast period.
For instance, as per the data stated by the Centres for Disease Control and Prevention, in the United States, RSV leads to an estimated 2.1 million outpatient visits among children below five years of age every year.
Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions.
